![]() |
市場調查報告書
商品編碼
1865403
全球微生物組檢測和個人化護膚市場:預測至2032年-按產品類型、成分類型、客製化方法、皮膚類型、皮膚狀況、樣本類型、最終用戶、分銷管道和地區進行分析Microbiome Testing & Personalized Skincare Market Forecasts to 2032 - Global Analysis By Product Type, Ingredient Type, Customization Method, Skin Type Focus, Skin Condition, Sample Type, End User, Distribution Channel, and By Geography |
||||||
根據 Stratistics MRC 的一項研究,預計到 2025 年,全球微生物組測試和個人化護膚市場價值將達到 4.893 億美元,到 2032 年將達到 11.161 億美元。
預計在預測期內,該領域將以12.5%的複合年成長率成長。護膚微生物組檢測是指分析個別皮膚微生物組,以識別其獨特的微生物組成。這些數據用於提供個人化的護膚方案,以支持和平衡皮膚的天然生態系統。個人化護膚利用這些洞察,提案針對特定皮膚問題(例如敏感、痤瘡或皮膚乾燥)的產品和療程。透過根據微生物組特徵定製配方,這種方法可以提高功效並促進皮膚健康,代表著精準皮膚病學和個人化健康策略的轉變。
皮膚疾病發生率上升與微生物群失衡有關。
與微生物群過度生長相關的皮膚疾病,例如痤瘡、濕疹和酒糟,日益增多,推動了消費者對針對性護膚解決方案的需求。消費者尋求能夠恢復微生物平衡的產品,促使各大品牌加大對微生物組檢測和個人化配方研發的投入。人們對皮膚健康和有益菌作用的認知不斷提高,進一步推動了這一趨勢。隨著臨床研究證實這些關聯,皮膚科醫生和健康專家的興趣日益濃厚,加速了整個護膚行業的創新和應用。
關於基因和微生物組資訊的資料隱私問題
消費者越來越謹慎地對待共用生物訊息,尤其是在直接面對消費者的測試模式下。監管審查的加強和缺乏標準化的資料保護框架進一步阻礙了此類服務的普及。企業必須在確保透明度和獲得用戶同意的同時,努力遵守GDPR和HIPAA等法規。這些隱私方面的挑戰可能會減緩消費者接受此類服務的速度,並限制個人化護膚平台的擴充性,尤其是在資料管治政策嚴格的地區。
拓展男士護膚市場
傳統上被忽視的男士護膚市場正面臨著日益成長的需求,消費者希望找到能夠解決特定肌膚問題的產品,例如剃須刺激、控油和老齡化。各大品牌正利用微生物組學的研究成果,發展針對不同性別的配方和行銷策略。此外,電子商務的興起和網紅影響力的提升,也幫助男士養成護膚習慣,為該領域的產品多元化和市場拓展創造了機會。
與現有護膚品牌的競爭
擁有穩固市場基礎和忠實基本客群的成熟護膚品牌對專注於微生物組的新興企業構成競爭威脅。這些老牌企業擁有廣泛的分銷網路、規模經濟和品牌信譽等優勢,使得新進業者難以立足市場。此外,傳統品牌正擴大將有益於微生物組的宣傳融入現有產品線,模糊了產品差異化。缺乏明確的科學檢驗和消費者教育,個人化微生物組解決方案容易被淹沒在傳統產品之中,從而延緩市場滲透和品牌認知度的提升。
新冠疫情對微生物組護膚市場產生了複雜的影響。雖然供應鏈中斷和商店銷售額下降最初阻礙了市場成長,但網路購物和自我護理習慣的興起創造了新的機會。消費者健康意識的增強推動了對個人化、實證護膚的興趣。此外,遠距諮詢和數位化平台也使得微生物組檢測服務得以持續進行。疫情加速了向電子商務和健康導向消費的轉變,最終凸顯了個人化護膚在後疫情時代消費行為的重要性。
預計在預測期內,外用藥物細分市場將佔據最大的市場佔有率。
由於其易用性和消費者熟悉度,預計外用製劑將在預測期內佔據最大的市場佔有率。這些產品直接作用於皮膚微生物群,使其成為開發個人化配方的理想選擇。此外,外用給藥系統可靈活添加益生元、益生菌和後生元,進而增強功效。較高的零售認知度和與現有護膚流程的親和性正在推動該領域的廣泛應用。在技術不斷創新的背景下,外用製劑仍將是基於微生物群的護膚解決方案的基礎。
預計在預測期內,後生元細分市場將呈現最高的複合年成長率。
由於其穩定性、安全性和已證實的護膚功效,預計後生元領域在預測期內將實現最高成長率。與活性益生菌不同,後生元由細菌代謝產物和細胞碎片組成,易於配製和儲存,因此對生產者極具吸引力。此外,後生元在臨床研究和研發領域正日益受到關注,進一步提升了其可信度。隨著監管政策的明朗化和公眾意識的不斷提高,預計該領域將在高階市場和大眾市場均實現快速成長。
預計在整個預測期內,北美將佔據最大的市場佔有率,這得益於其先進的皮膚病學基礎設施、較高的消費者意識以及生物技術Start-Ups的強大實力。尤其是在美國,個人化護膚的普及速度很快,這主要得益於其強大的電子商務管道和日益成長的健康意識。監管機構對創新的支持以及越來越多的健康意識消費者進一步鞏固了該地區的優勢。護膚品牌與研究機構之間的策略合作也有助於提升產品的可信度。
預計亞太地區在預測期內將實現最高的複合年成長率,這主要得益於可支配收入的成長、美容意識的提高以及對個性化解決方案需求的不斷成長。韓國、日本和中國等國家在護膚創新方面處於領先地位,消費者對注重微生物群的產品趨之若鶓。該地區整體健康理念和對天然成分的文化重視與基於微生物群的配方完美契合。此外,數位平台和網紅行銷的興起也加速了產品認知度的提升。
According to Stratistics MRC, the Global Microbiome Testing & Personalized Skincare Market is accounted for $489.3 million in 2025 and is expected to reach $1,116.1 million by 2032, growing at a CAGR of 12.5% during the forecast period. Microbiome testing in skincare involves analyzing an individual's skin microbiota to identify the unique composition of microorganisms present. This data informs personalized skincare solutions tailored to support and balance the skin's natural ecosystem. Personalized skincare leverages these insights to recommend targeted products and routines that address specific skin concerns, such as sensitivity, acne, or dryness. By aligning formulations with microbiome profiles, this approach enhances efficacy, promotes skin health, and represents a shift toward precision dermatology and individualized wellness strategies.
Rising prevalence of skin conditions linked to microbiome imbalance
The increasing incidence of skin disorders such as acne, eczema, and rosacea often associated with microbiome dysbiosis is driving demand for targeted skincare solutions. Consumers are seeking products that restore microbial balance, prompting brands to invest in microbiome testing and personalized formulations. This trend is further supported by growing awareness of skin health and the role of beneficial bacteria. As clinical research validates these links, the market is witnessing heightened interest from dermatologists and wellness professionals, thereby accelerating innovation and adoption across skincare categories.
Data privacy concerns regarding genetic and microbiome information
Consumers are increasingly cautious about sharing biological information, especially in direct-to-consumer testing models. Regulatory scrutiny and lack of standardized data protection frameworks further complicate adoption. Companies must navigate compliance with GDPR and HIPAA while ensuring transparency and consent. These privacy challenges may slow down consumer onboarding and limit the scalability of personalized skincare platforms, particularly in regions with stringent data governance policies.
Expansion into men's skincare
Traditionally underserved, the men's skincare segment is now witnessing increased demand for targeted solutions addressing issues like shaving irritation, oil control, and aging. Brands are leveraging microbiome insights to develop gender-specific formulations and marketing strategies. Moreover, the rise of e-commerce and influencer-driven awareness is helping normalize skincare routines among men, creating a fertile ground for product diversification and market expansion in this demographic.
Competition from traditional skincare brands
Established skincare brands with strong market presence and loyal customer bases pose a competitive threat to microbiome-focused startups. These incumbents often benefit from extensive distribution networks, economies of scale, and brand trust, making it challenging for newer entrants to gain traction. Additionally, traditional brands are increasingly incorporating microbiome-friendly claims into their existing product lines, blurring differentiation. Without clear scientific validation and consumer education, personalized microbiome solutions risk being overshadowed by conventional offerings, potentially slowing market penetration and brand recognition.
The COVID-19 pandemic had a mixed impact on the microbiome skincare market. While supply chain disruptions and reduced in-store purchases initially hindered growth, the surge in online shopping and self-care routines created new opportunities. Consumers became more health-conscious, driving interest in personalized and science-backed skincare. Moreover, remote consultations and digital platforms enabled continued engagement with microbiome testing services. The pandemic accelerated the shift toward e-commerce and wellness-driven consumption, ultimately reinforcing the relevance of personalized skincare in post-pandemic consumer behavior.
The topical formats segment is expected to be the largest during the forecast period
The topical formats segment is expected to account for the largest market share during the forecast period due to their ease of application and consumer familiarity. These products allow for direct interaction with the skin's microbiota, making them ideal for personalized formulations. Additionally, topical delivery systems offer flexibility in incorporating prebiotics, probiotics, and postbiotics, enhancing efficacy. The segment benefits from strong retail visibility and compatibility with existing skincare routines, which supports widespread adoption. As innovation continues, topical formats remain the cornerstone of microbiome-based skincare solutions.
The postbiotics segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the postbiotics segment is predicted to witness the highest growth rate owing to their stability, safety, and proven skin benefits. Unlike live probiotics, postbiotics comprising bacterial metabolites and cell fragments are easier to formulate and store, making them attractive for manufacturers. Furthermore, postbiotics are gaining traction in clinical research and product development, reinforcing their credibility. As regulatory clarity improves and awareness grows, this segment is poised for rapid expansion across both premium and mass-market offerings.
During the forecast period, the North America region is expected to hold the largest market share propelled by its advanced dermatological infrastructure, high consumer awareness, and strong presence of biotech startups. The U.S. in particular has seen early adoption of personalized skincare, supported by robust e-commerce channels and wellness trends. Regulatory support for innovation and a growing base of health-conscious consumers further contribute to regional dominance. Strategic collaborations between skincare brands and research institutions also enhance product credibility.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by rising disposable incomes, expanding beauty consciousness, and increasing demand for personalized solutions. Countries like South Korea, Japan, and China are at the forefront of skincare innovation, with consumers embracing microbiome-friendly products. The region's cultural emphasis on holistic wellness and natural ingredients aligns well with microbiome-based formulations. Moreover, the proliferation of digital platforms and influencer marketing is accelerating product awareness.
Key players in the market
Some of the key players in Microbiome Testing & Personalized Skincare Market include Viome Life Sciences, Inc., DayTwo Inc., ZOE Limited, Pendulum Therapeutics, Inc., Microba Life Sciences Pty Ltd, Atlas Biomed Group Ltd, Sun Genomics, Inc., Microbiome Insights, Inc., CosmosID, Inc., Givaudan SA, Unilever PLC, L'Oreal S.A., Parallel Health, Inc., Azitra, Inc., Eligo Bioscience SA, and Codex Labs UK Limited.
In July 2025, Viome partnered with Microsoft to scale its RNA-based health platform using AI and cloud computing, offering at-home testing kits analyzing saliva, blood, and stool samples for personalized diet, supplements, and oral care products including a personalized oral microbiome toothpaste "MyBiotics.
In June 2025, Viome acquired digital health company Naring Health to enhance personalized nutrition and longevity solutions, combining clinical data and food-genetic insights.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.